Liabilities and Equity of ICU MEDICAL INC/DE from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
ICU MEDICAL INC/DE quarterly Liabilities and Equity in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • ICU MEDICAL INC/DE Liabilities and Equity for the quarter ending 31 Dec 2025 was $4,050,508,000, a 3.6% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

ICU MEDICAL INC/DE Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $4,050,508,000 -$153,423,000 -3.6% 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q3 2025 $4,102,896,000 -$202,142,000 -4.7% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $4,107,389,000 -$179,278,000 -4.2% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $4,184,581,000 -$103,817,000 -2.4% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $4,203,931,000 -$174,508,000 -4% 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q3 2024 $4,305,038,000 -$71,826,000 -1.6% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $4,286,667,000 -$176,377,000 -4% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $4,288,398,000 -$182,234,000 -4.1% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $4,378,439,000 -$137,202,000 -3% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $4,376,864,000 -$73,613,000 -1.7% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $4,463,044,000 -$126,951,000 -2.8% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $4,470,632,000 -$276,100,000 -5.8% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $4,515,641,000 +$2,634,903,000 +140% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $4,450,477,000 +$2,611,126,000 +142% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $4,589,995,000 +$2,787,153,000 +155% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $4,746,732,000 +$2,981,502,000 +169% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $1,880,738,000 +$117,047,000 +6.6% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $1,839,351,000 +$109,815,000 +6.3% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $1,802,842,000 -$56,220,000 -3% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q1
Q1 2021 $1,765,230,000 -$51,749,000 -2.8% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $1,763,691,000 +$71,309,000 +4.2% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $1,729,536,000 +$91,752,000 +5.6% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $1,859,062,000 +$236,145,000 +15% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $1,816,979,000 +$203,708,000 +13% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $1,692,382,000 +$106,991,000 +6.7% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $1,637,784,000 +$92,609,000 +6% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $1,622,917,000 +$96,573,000 +6.3% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $1,613,271,000 +$120,529,000 +8.1% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $1,585,391,000 +$88,440,000 +5.9% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $1,545,175,000 +$22,201,000 +1.5% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $1,526,344,000 +$39,047,000 +2.6% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $1,492,742,000 +$19,706,000 +1.3% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $1,496,951,000 +$792,263,000 +112% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 $1,522,974,000 +$834,275,000 +121% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $1,487,297,000 +$823,918,000 +124% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $1,473,036,000 +$837,079,000 +132% 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 $704,688,000 +$77,863,000 +12% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q3 2016 $688,699,000 +$78,471,000 +13% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $663,379,000 +$93,142,000 +16% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $635,957,000 +$81,613,000 +15% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 $626,825,000 +$85,723,000 +16% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 $610,228,000 +$82,512,000 +16% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $570,237,000 +$50,720,000 +9.8% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 $554,344,000 +$47,912,000 +9.5% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 $541,102,000 +$41,459,000 +8.3% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q3 2014 $527,716,000 +$59,035,000 +13% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 $519,517,000 +$67,955,000 +15% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 $506,432,000 +$68,550,000 +16% 31 Mar 2014 10-Q 07 May 2014 2014 Q1
Q4 2013 $499,643,000 +$71,131,000 +17% 31 Dec 2013 10-K 20 Feb 2015 2014 FY
Q3 2013 $468,681,000 +$55,774,000 +14% 30 Sep 2013 10-Q 22 Oct 2013 2013 Q3
Q2 2013 $451,562,000 +$58,971,000 +15% 30 Jun 2013 10-Q 25 Jul 2013 2013 Q2
Q1 2013 $437,882,000 +$61,398,000 +16% 31 Mar 2013 10-Q 22 Apr 2013 2013 Q1
Q4 2012 $428,512,000 +$67,400,000 +19% 31 Dec 2012 10-K 21 Feb 2014 2013 FY
Q3 2012 $412,907,000 +$69,400,000 +20% 30 Sep 2012 10-Q 19 Oct 2012 2012 Q3
Q2 2012 $392,591,000 +$46,262,000 +13% 30 Jun 2012 10-Q 20 Jul 2012 2012 Q2
Q1 2012 $376,484,000 +$47,289,000 +14% 31 Mar 2012 10-Q 20 Apr 2012 2012 Q1
Q4 2011 $361,112,000 +$51,468,000 +17% 31 Dec 2011 10-K 26 Feb 2013 2012 FY
Q3 2011 $343,507,000 +$43,084,000 +14% 30 Sep 2011 10-Q/A 08 Dec 2011 2011 Q3
Q2 2011 $346,329,000 +$59,655,000 +21% 30 Jun 2011 10-Q/A 08 Dec 2011 2011 Q2
Q1 2011 $329,195,000 +$42,294,000 +15% 31 Mar 2011 10-Q 22 Apr 2011 2011 Q1
Q4 2010 $309,644,000 31 Dec 2010 10-K 23 Mar 2012 2011 FY
Q3 2010 $300,423,000 30 Sep 2010 10-Q 22 Oct 2010 2010 Q3
Q2 2010 $286,674,000 30 Jun 2010 10-Q 23 Jul 2010 2010 Q2
Q1 2010 $286,901,000 31 Mar 2010 10-Q 23 Apr 2010 2010 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.